期刊文献+

对不同性质乳腺组织中乳腺干细胞比例的测定 被引量:1

Measurement of Proportion of Mammary Stem Cell in Different Mammary Tissue
暂未订购
导出
摘要 目的:了解乳腺干细胞在不同性质的乳腺组织中的含量。方法:取得手术后不同性质的乳腺组织,用胶原酶消化法制备成单细胞悬液后,采用流式细胞技术测定乳腺细胞的CD44和CD24表达情况。结果:从正常、乳腺疾病到乳腺癌组织,CD44+CD24-/low乳腺细胞的比例上升;当乳腺癌细胞生长加速时,CD44+CD24+乳腺细胞比例明显增加。结论:乳腺干细胞的含量可以反映乳腺组织的性质,而CD44+CD24+乳腺细胞可能是祖细胞,并且其含量可以反映乳腺组织的生长情况。 Objective: To know the proportion of mammary stem cell in different mammary tissue. Methods: obtaioned differcur mammary tissue after operation and then prepared single cell suspensions by collagenase, and measured the expression of CD44 and CD24 of the mammary cells. Results: From normal, benign to malignant mammary tissues, the proporation of CD44^+ CD24^-/low of the mammary cells gradually increased. When proliferation of mammaty cancer cells was accelerated, the proporation of CD44^+ CD24^+ of the mammary cell also markedly increased. Conclusions: The proporation of mammary stem cells could reflect the property of mammary tissue. CD44^+ CD24^+ of the mammary cells were mammary progenitor cell, and its proporafion could reflect the proliferation of mammary tissue.
出处 《华西医学》 CAS 2006年第3期442-444,共3页 West China Medical Journal
关键词 干细胞 祖细胞 乳腺癌 自我更新 stem cell progenitor cell breast cancer self- renewal
  • 相关文献

参考文献9

  • 1T Reya,SJ Morrison,MF Clarke.Stem cells,cancer and cancer stem cells[J].Nature,2001,414(6859):105-111.
  • 2Keith R.Brennan,Anthony M.C.Brown.Wnt Proteins in Mammary Development and Cancer[J].J of Mammary Gland Bio and Neo,2004,2(9):119-131.
  • 3Bonnet D,Dick JE.Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell[J].Nature,1997,3:730-737.
  • 4Singh SK,Clarke ID,Terasaki M,et al.Identification of a cancer stem cell in human brain tumors[J].Cancer Res,2003,63(18):5821-5828.
  • 5Al-Hajj M,Wicha MS,Benito HA,et al.Prospective identification of tumorigenic breast cancer cells[J].PNAS,2003,100(7):3983-3988.
  • 6Charlotte K,Tony C,Min Wu et al.Reconstruction of functionally normal and malignant human breast tissues in mice[J].PNAS,2004,101(14):4966-4971.
  • 7Tsukamoto AS,Grosschedl R,Guzman RC et al.Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocar-cinomas in male and female mice[J].Cell,1988,55:619-625.
  • 8Li Y,Hively WP,Varmus HE.Use of MMTV-Wnt-1 transgenic mice for studying the genetic basis of breast cancer[J].Oncogene,2000,19(8):1002-1009.
  • 9Gunther EJ,Moody SE,Belka GK et al.Impact of p53 loss on reversal and recurrence of conditional Wnt-induced tumorigenesis[J].Genes Dev,2003,17(4):488-501.

同被引文献64

  • 1Clayton H, Titley I, Vivanco M. Growth and differentiation of progenitor/stem ceils derived from the human mammary gland [ J]. Exp Cell Res,2004,297(2) :444 -460.
  • 2Kubo M, Nakamura M, Tasaki A, et al. Hedgehog signaling pathway is a new therapeutic target for patients with breast cancer [ J ]. Cancer Res ,2004,64 ( 17 ) :6071-6074.
  • 3Gaiano N, Fishell G. The role of notch in promoting glial and neural stem cell fates[J]. Annu RevNeurosci ,2002,25:471 -490.
  • 4Doutu G, Patel S, Mantle ID, et al. Role of Notch signaling in cellfate determination of human mammary stem/progenitor cells [ J ]. Breast Cancer Res,2004,6(6) : 605 -615.
  • 5Levi BP,Yilmaz OH, Duester G,et al. Aldehyde dehydrogenase 1 al is dispensable for stem cell function in the mouse hematopoietic and nervous systems [ J ]. Blood,2009,113 (8) : 1670-1680.
  • 6Corkery B, Crown J, Clynes M, et al. Epidermal growth factor receptor as a potential therapeutic target in triple-negative breast cancer [J]. Ann Onco1,2009,20 (5) :862-867.
  • 7Baselga J,Averbuch SD. ZD1839 ( ' Iressa' ) as an anticancer agent[J]. Drugs,2000,60 Suppl 1:33 -40.
  • 8Goldstein NI, Prewett M, Zuklys K, et al. Biological efficacy of a chimeric antibody to the epidermal growth factor receptor in a human tumor xenograft model [J]. Clin Cancer Res, 1995,1 ( 11 ) : 1311 -1318.
  • 9McKillop D, Partridge EA, Kemp JV, et al. Tumor penetration of gefitinib ( Iressa), an epidermal growth factor receptor tyrosine kinase inhibitor[ J ]. Mol Cancer Ther,2005,4 (4) :641-649.
  • 10Hoadley KA, Weigman VJ, Fan C, et al. EGFR associated expression profiles vary with breast tumor subtype [ J ]. BMC Genomics, 2007,8:258.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部